AI Verdict
JYNT has stronger fundamentals based on our AI analysis.
KAPA vs JYNT Fundamental Comparison
| Metric | KAPA | JYNT |
|---|---|---|
| Revenue | N/A | $54.9M |
| Net Income | $-5.4M | $2.9M |
| Net Margin | N/A | 5.3% |
| ROE | -85.9% | 19.3% |
| ROA | -83.3% | 4.8% |
| Current Ratio | 27.07x | 1.59x |
| Debt/Equity | 0.00x | 0.01x |
| EPS | $-0.30 | $0.19 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KAPA vs JYNT: Frequently Asked Questions
Is KAPA or JYNT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), JYNT has stronger fundamentals. KAPA is rated SELL (85% confidence) while JYNT is rated HOLD (65% confidence). This is not investment advice.
How does KAPA compare to JYNT fundamentally?
Kairos Pharma, LTD. has ROE of -85.9% vs JOINT Corp's 19.3%. Net margins are N/A vs 5.3% respectively.
Which stock pays higher dividends, KAPA or JYNT?
KAPA has a dividend yield of N/A or no dividend while JYNT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KAPA or JYNT for long term?
For long-term investing, consider that KAPA has SELL rating with 85% confidence, while JYNT has HOLD rating with 65% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KAPA vs JYNT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KAPA vs JYNT, the AI consensus favors JYNT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.